Selected research
Industry Research
Endocrine Testing Service Industry Research Report 2026
Market perspective
The global Endocrine Testing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Endocrine Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Endocrine Testing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Endocrine Testing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Endocrine Testing Service include Hoffmann-La Roche Ltd., Abbott Laboratories, Agilent Technologies, BioMerieux S.A., Bio-Rad Laboratories, Inc., Siemens Healthineers, Danaher Corporation, DiaSorin S.p.A. and Immunodiagnostic Systems, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Endocrine Testing Service market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Endocrine Testing Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Endocrine Testing Service Market by Company
Hoffmann-La Roche Ltd.
Abbott Laboratories
Agilent Technologies
BioMerieux S.A.
Bio-Rad Laboratories, Inc.
Siemens Healthineers
Danaher Corporation
DiaSorin S.p.A.
Immunodiagnostic Systems
Laboratory Corporation of America Holdings
Fujirebio, Inc.
Thermo Fisher Scientific Inc.
Quest Diagnostics
Sysmex Corporation
MP Biomedicals
Ortho Clinical Diagnostics
Meridian Life Science, Inc.
Endocrine Testing Service Segment by Type
Prolactin Testing
Progesterone Testing
Testosterone Testing
Endocrine Testing Service Segment by Application
Hospitals
Clinics
Endocrine Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endocrine Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Endocrine Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endocrine Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Endocrine Testing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Prolactin Testing
- Progesterone Testing
- Testosterone Testing
Applications
- Hospitals
- Clinics
Companies covered
- Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Agilent Technologies
- BioMerieux S.A.
- Bio-Rad Laboratories, Inc.
- Siemens Healthineers
- Danaher Corporation
- DiaSorin S.p.A.
- Immunodiagnostic Systems
- Laboratory Corporation of America Holdings
- Fujirebio, Inc.
- Thermo Fisher Scientific Inc.
- Quest Diagnostics
- Sysmex Corporation
- MP Biomedicals
- Ortho Clinical Diagnostics
- Meridian Life Science, Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Endocrine Testing Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Prolactin Testing
- 2.2.3 Progesterone Testing
- 2.2.4 Testosterone Testing
- 2.3 Endocrine Testing Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Clinics
- 2.4 Assumptions and Limitations
3 Endocrine Testing Service Breakdown Data by Type
- 3.1 Global Endocrine Testing Service Historic Market Size by Type (2021-2026)
- 3.2 Global Endocrine Testing Service Forecasted Market Size by Type (2027-2032)
4 Endocrine Testing Service Breakdown Data by Application
- 4.1 Global Endocrine Testing Service Historic Market Size by Application (2021-2026)
- 4.2 Global Endocrine Testing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Endocrine Testing Service Market Perspective (2021-2032)
- 5.2 Global Endocrine Testing Service Growth Trends by Region
- 5.2.1 Global Endocrine Testing Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Endocrine Testing Service Historic Market Size by Region (2021-2026)
- 5.2.3 Endocrine Testing Service Forecasted Market Size by Region (2027-2032)
- 5.3 Endocrine Testing Service Market Dynamics
- 5.3.1 Endocrine Testing Service Industry Trends
- 5.3.2 Endocrine Testing Service Market Drivers
- 5.3.3 Endocrine Testing Service Market Challenges
- 5.3.4 Endocrine Testing Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Endocrine Testing Service Players by Revenue
- 6.1.1 Global Top Endocrine Testing Service Players by Revenue (2021-2026)
- 6.1.2 Global Endocrine Testing Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Endocrine Testing Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Endocrine Testing Service Head Office and Area Served
- 6.4 Global Endocrine Testing Service Players, Product Type & Application
- 6.5 Global Endocrine Testing Service Manufacturers Established Date
- 6.6 Global Endocrine Testing Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Endocrine Testing Service Market Size (2021-2032)
- 7.2 North America Endocrine Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Endocrine Testing Service Market Size by Country (2021-2026)
- 7.4 North America Endocrine Testing Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Endocrine Testing Service Market Size (2021-2032)
- 8.2 Europe Endocrine Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Endocrine Testing Service Market Size by Country (2021-2026)
- 8.4 Europe Endocrine Testing Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Endocrine Testing Service Market Size (2021-2032)
- 9.2 Asia-Pacific Endocrine Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Endocrine Testing Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Endocrine Testing Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Endocrine Testing Service Market Size (2021-2032)
- 10.2 South America Endocrine Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Endocrine Testing Service Market Size by Country (2021-2026)
- 10.4 South America Endocrine Testing Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Endocrine Testing Service Market Size (2021-2032)
- 11.2 Middle East & Africa Endocrine Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Endocrine Testing Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Endocrine Testing Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Hoffmann-La Roche Ltd.
- 12.1.1 Hoffmann-La Roche Ltd. Company Information
- 12.1.2 Hoffmann-La Roche Ltd. Business Overview
- 12.1.3 Hoffmann-La Roche Ltd. Revenue in Endocrine Testing Service Business (2021-2026)
- 12.1.4 Hoffmann-La Roche Ltd. Endocrine Testing Service Product Portfolio
- 12.1.5 Hoffmann-La Roche Ltd. Recent Developments
- 12.2 Abbott Laboratories
- 12.2.1 Abbott Laboratories Company Information
- 12.2.2 Abbott Laboratories Business Overview
- 12.2.3 Abbott Laboratories Revenue in Endocrine Testing Service Business (2021-2026)
- 12.2.4 Abbott Laboratories Endocrine Testing Service Product Portfolio
- 12.2.5 Abbott Laboratories Recent Developments
- 12.3 Agilent Technologies
- 12.3.1 Agilent Technologies Company Information
- 12.3.2 Agilent Technologies Business Overview
- 12.3.3 Agilent Technologies Revenue in Endocrine Testing Service Business (2021-2026)
- 12.3.4 Agilent Technologies Endocrine Testing Service Product Portfolio
- 12.3.5 Agilent Technologies Recent Developments
- 12.4 BioMerieux S.A.
- 12.4.1 BioMerieux S.A. Company Information
- 12.4.2 BioMerieux S.A. Business Overview
- 12.4.3 BioMerieux S.A. Revenue in Endocrine Testing Service Business (2021-2026)
- 12.4.4 BioMerieux S.A. Endocrine Testing Service Product Portfolio
- 12.4.5 BioMerieux S.A. Recent Developments
- 12.5 Bio-Rad Laboratories, Inc.
- 12.5.1 Bio-Rad Laboratories, Inc. Company Information
- 12.5.2 Bio-Rad Laboratories, Inc. Business Overview
- 12.5.3 Bio-Rad Laboratories, Inc. Revenue in Endocrine Testing Service Business (2021-2026)
- 12.5.4 Bio-Rad Laboratories, Inc. Endocrine Testing Service Product Portfolio
- 12.5.5 Bio-Rad Laboratories, Inc. Recent Developments
- 12.6 Siemens Healthineers
- 12.6.1 Siemens Healthineers Company Information
- 12.6.2 Siemens Healthineers Business Overview
- 12.6.3 Siemens Healthineers Revenue in Endocrine Testing Service Business (2021-2026)
- 12.6.4 Siemens Healthineers Endocrine Testing Service Product Portfolio
- 12.6.5 Siemens Healthineers Recent Developments
- 12.7 Danaher Corporation
- 12.7.1 Danaher Corporation Company Information
- 12.7.2 Danaher Corporation Business Overview
- 12.7.3 Danaher Corporation Revenue in Endocrine Testing Service Business (2021-2026)
- 12.7.4 Danaher Corporation Endocrine Testing Service Product Portfolio
- 12.7.5 Danaher Corporation Recent Developments
- 12.8 DiaSorin S.p.A.
- 12.8.1 DiaSorin S.p.A. Company Information
- 12.8.2 DiaSorin S.p.A. Business Overview
- 12.8.3 DiaSorin S.p.A. Revenue in Endocrine Testing Service Business (2021-2026)
- 12.8.4 DiaSorin S.p.A. Endocrine Testing Service Product Portfolio
- 12.8.5 DiaSorin S.p.A. Recent Developments
- 12.9 Immunodiagnostic Systems
- 12.9.1 Immunodiagnostic Systems Company Information
- 12.9.2 Immunodiagnostic Systems Business Overview
- 12.9.3 Immunodiagnostic Systems Revenue in Endocrine Testing Service Business (2021-2026)
- 12.9.4 Immunodiagnostic Systems Endocrine Testing Service Product Portfolio
- 12.9.5 Immunodiagnostic Systems Recent Developments
- 12.10 Laboratory Corporation of America Holdings
- 12.10.1 Laboratory Corporation of America Holdings Company Information
- 12.10.2 Laboratory Corporation of America Holdings Business Overview
- 12.10.3 Laboratory Corporation of America Holdings Revenue in Endocrine Testing Service Business (2021-2026)
- 12.10.4 Laboratory Corporation of America Holdings Endocrine Testing Service Product Portfolio
- 12.10.5 Laboratory Corporation of America Holdings Recent Developments
- 12.11 Fujirebio, Inc.
- 12.11.1 Fujirebio, Inc. Company Information
- 12.11.2 Fujirebio, Inc. Business Overview
- 12.11.3 Fujirebio, Inc. Revenue in Endocrine Testing Service Business (2021-2026)
- 12.11.4 Fujirebio, Inc. Endocrine Testing Service Product Portfolio
- 12.11.5 Fujirebio, Inc. Recent Developments
- 12.12 Thermo Fisher Scientific Inc.
- 12.12.1 Thermo Fisher Scientific Inc. Company Information
- 12.12.2 Thermo Fisher Scientific Inc. Business Overview
- 12.12.3 Thermo Fisher Scientific Inc. Revenue in Endocrine Testing Service Business (2021-2026)
- 12.12.4 Thermo Fisher Scientific Inc. Endocrine Testing Service Product Portfolio
- 12.12.5 Thermo Fisher Scientific Inc. Recent Developments
- 12.13 Quest Diagnostics
- 12.13.1 Quest Diagnostics Company Information
- 12.13.2 Quest Diagnostics Business Overview
- 12.13.3 Quest Diagnostics Revenue in Endocrine Testing Service Business (2021-2026)
- 12.13.4 Quest Diagnostics Endocrine Testing Service Product Portfolio
- 12.13.5 Quest Diagnostics Recent Developments
- 12.14 Sysmex Corporation
- 12.14.1 Sysmex Corporation Company Information
- 12.14.2 Sysmex Corporation Business Overview
- 12.14.3 Sysmex Corporation Revenue in Endocrine Testing Service Business (2021-2026)
- 12.14.4 Sysmex Corporation Endocrine Testing Service Product Portfolio
- 12.14.5 Sysmex Corporation Recent Developments
- 12.15 MP Biomedicals
- 12.15.1 MP Biomedicals Company Information
- 12.15.2 MP Biomedicals Business Overview
- 12.15.3 MP Biomedicals Revenue in Endocrine Testing Service Business (2021-2026)
- 12.15.4 MP Biomedicals Endocrine Testing Service Product Portfolio
- 12.15.5 MP Biomedicals Recent Developments
- 12.16 Ortho Clinical Diagnostics
- 12.16.1 Ortho Clinical Diagnostics Company Information
- 12.16.2 Ortho Clinical Diagnostics Business Overview
- 12.16.3 Ortho Clinical Diagnostics Revenue in Endocrine Testing Service Business (2021-2026)
- 12.16.4 Ortho Clinical Diagnostics Endocrine Testing Service Product Portfolio
- 12.16.5 Ortho Clinical Diagnostics Recent Developments
- 12.17 Meridian Life Science, Inc.
- 12.17.1 Meridian Life Science, Inc. Company Information
- 12.17.2 Meridian Life Science, Inc. Business Overview
- 12.17.3 Meridian Life Science, Inc. Revenue in Endocrine Testing Service Business (2021-2026)
- 12.17.4 Meridian Life Science, Inc. Endocrine Testing Service Product Portfolio
- 12.17.5 Meridian Life Science, Inc. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst